US watchdog warns on fitness stimulant
The US Food and Drug Administration on Friday questioned the safety of DMAA, a stimulant used in dietary supplements, alleging that marketers were illegally selling the chemical.
Popular with fitness buffs seeking an edge or weight loss, the brands include Napalm, Code Red, Hemo Rage Black, Nitric Blast and Jack3D.
The FDA said it issued warning letters to 10 manufacturers and distributors of dietary supplements containing the ingredient for failing to submit evidence of the safety of their products.
"Before marketing products containing DMAA, manufacturers and distributors have a responsibility under the law to provide evidence of the safety of their products. They haven't done that and that makes the products adulterated," said Daniel Fabricant, director of the FDA's Dietary Supplement Program.
In the warning letters, the FDA also said it was not aware of evidence or history of use to indicate that DMAA is safe.
Dimethylamylamine, also referred to as "geranium extract," is often touted as a "natural" stimulant, the FDA said.
"The agency additionally warned the companies that synthetically produced DMAA is not a 'dietary ingredient' and, therefore, is not eligible to be used as an active ingredient in a dietary supplement," the agency said.
The FDA letters raised concerns that DMAA is known to narrow blood vessels and arteries, which can lead to shortness of breath and heart attack.
The federal agency said it had received 42 adverse reports on products containing DMAA, including psychiatric disorders and death.
In December, the Army Times reported the Defense Department had ordered an end to on-base sales of a number of workout supplements containing DMAA, pending a review of its safety.
The Pentagon worried that the substance may have contributed to the deaths of two soldiers who had heart attacks during physical training after using DMAA products, as well as the cases of three soldiers and two Marines who collapsed during heavy exercise, the specialty newspaper reported.
The FDA said the firms have 15 business days to respond with the specific steps they will take to address the issues in the warning letters.
The 10 companies warned are: Exclusive Supplements, Fahrenheit Nutrition, Gaspari Nutrition, iSatori Global Technologies, Muscle Warfare, MuscleMeds Performance Technologies, Nutrex Research, SEI Pharmaceuticals, SNI, and USP Labs.
(c) 2012 AFP
-
FDA issues supplement rules
Jun 23, 2007 |
not rated yet |
0
-
FDA warns about dietary supplements
Mar 26, 2008 |
not rated yet |
0
-
FDA cracks down on illegal supplements
Dec 15, 2010 |
not rated yet |
0
-
Nanotech in your vitamins
Jan 14, 2009 |
not rated yet |
0
-
FDA urges consumers to avoid sexual-enhancement drinks
Jan 03, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be villous adenoma in colon, if there are no villi there
20 hours ago
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
9 hours ago |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
11 hours ago |
not rated yet |
0
Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
Medications
16 hours ago |
not rated yet |
0
Succesful results in developing oral vaccine against diarrhea
The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.
Medications
19 hours ago |
not rated yet |
0
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Medications
May 21, 2013 |
4.2 / 5 (5) |
0
Slowing the aging process—only with antibiotics
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
Rate of bicycle-related fatalities significantly lower in states with helmet laws
Existing research shows that bicyclists who wear helmets have an 88 percent lower risk of brain injury, but researchers at Boston Children's Hospital found that simply having bicycle helmet laws in place showed a 20 percent ...
Researchers complete largest genetic sequencing study of human disease
Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Having both migraines, depression may mean smaller brain
(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.
Novel approach for influenza vaccination shows promise in early animal testing
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
Apr 28, 2012
Rank: not rated yet